| Acquirer | Target | Price |
|---|---|---|
| Piramal Critical Care Inc. | Mallinckrodt's intrathecal therapy business | $203 million |
| Incyte Corporation | License to CB-1158 | $45 million |
| CareTrust REIT, Inc. | 2 memory care companies | $26.1 million |
| Diplomat Pharmacy, Inc. | Affinity Biotech Inc. | $16 million |
| Regional hospital systems | Wingate at Melrose | $3.6 million |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
